Leading the way in Infection Prevention and Wound Care Solutions
Bravida is redefining what’s possible in wound care and infection prevention, with a portfolio of transformative products and technologies that are clinically proven to deliver uncompromising freedom and protection.
Our Brands
Men’s Liberty
A discreet external male urinary collection device designed to manage urinary incontinence effectively in combination with world class securement solutions
Silverlon
Wound dressings that have a silver plated technology delivering antimicrobial benefits in the dressing without staining the skin and without increasing bioburden
Bravida’s Innovative Solutions Impact Clinical Outcomes:
Wound Care
Chronic wounds impact the quality of life of many people across the globe. For example, in the United States, it affects nearly 2.5% (more than 8 million people).
Urology
In the United States, up to 80% of complicated urinary tract infections are attributable to indwelling urinary catheters. (36)
Vascular Access
CLABSIs are associated with a high-cost burden, accounting for approximately $46,000 per case. (34)
Surgical Site
Infections
Surgical site infections are the most frequent type of healthcare-associated infections, accounting for 14% − 25% of the total hospital-acquired infections. (32)
Burn
Methicillin-resistant S. aureus now is one of the leading organisms causing invasive infection in burns across the world, with burn units reporting rates of infection greater than 50%. (38)
Mechanical Circulatory Support
The overall mortality for driveline infection was 11.5%. (33)
Hospital-acquired infections during ECMO is 10–12% and their occurrence is likely to be more frequent compared with other critically ill patients. (40)
Chronic wounds impact the quality of life of nearly 2.5% (more than 8 million people) of the total population in the U.S. and the management of wounds has a significant economic impact on health care. (35)
In the United States, up to 80% of complicated urinary tract infections are attributable to indwelling urinary catheters. (36)
Up to 95% of patients will develop moderate-to-severe skin reactions due to radiation. (37) Additionally, Methicillin-resistant S. aureus now is one of the leading organisms causing invasive infection in burns across the world, with burn units reporting rates of infection greater than 50% (38)
Surgical site infections are the most frequent type of healthcare-associated infections, accounting for 14% − 25% of the total hospital-acquired infections (32)
Methicillin-resistant S. aureus now is one of the leading organisms causing invasive infection in burns across the world, with burn units reporting rates of infection greater than 50% (38)
Some of Our Products
Discover the benefits that Bravida Medical products can offer your patients.